Correction: RON signalling promotes therapeutic resistance in ESR1 mutant breast cancer. Dustin D, Gu G, Beyer AR, Herzog SK, et al. Br J Cancer 2025 Sep 1. doi: 10.1038/s41416-025-03096.

Read + Share

Amedeo Smart

Independent Medical Education

Dustin D, Gu G, Beyer AR, Herzog SK, et al. Correction: RON signalling promotes therapeutic resistance in ESR1 mutant breast cancer. Br J Cancer 2025 Sep 1. doi: 10.1038/s41416-025-03096.
PMID: 40890299